SCHEMBL599276

SCHEMBL599276

Cc1ccc2ccc3ccc(C)cc3c2c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.65
CYP2A6 P11509 4/20 0.65
TDP1 Q9NUW8 4/20 0.52
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 2/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
ACHE P22303 2/20 0.44
MAOA P21397 1/20 0.44
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
NOX1 Q9Y5S8 1/20 0.41
TYMS P04818 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30694959 1.00 CYP1A2 (0.65) CYP1A2CYP2A6TDP1ALDH1A1LMNA
SCHEMBL598308 0.89 CYP1A2 (0.60) CYP1A2CYP2A6TDP1ALDH1A1LMNA
SCHEMBL167985 0.87 CYP2A6 (0.64) CYP1A2CYP2A6TDP1ALDH1A1GAA
SCHEMBL23618575 0.84 CYP1A2 (0.50) CYP1A2CYP2A6TDP1ALDH1A1LMNA
SCHEMBL17281129 0.84 CYP2A6 (0.50) CYP1A2CYP2A6TDP1ALDH1A1LMNA
SCHEMBL10028805 0.83 CYP2A6 (0.54) CYP1A2CYP2A6TDP1ALDH1A1LMNA
SCHEMBL30159693 0.83 TRPA1 (0.52) CYP1A2CYP2A6TDP1ALDH1A1LMNA
SCHEMBL28043581 0.83 CYP2A6 (0.62) CYP1A2CYP2A6TDP1ALDH1A1LMNA
SCHEMBL599225 0.83 HPRT1 (0.64) CYP1A2CYP2A6TDP1ALDH1A1GAA
SCHEMBL28664564 0.83 TRPA1 (0.52) CYP1A2CYP2A6TDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11029303-B2 PAH antibodies and uses thereof THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2021-06-08 US claimed
WO-2016196638-A2 PAH ANTIBODIES AND USES THEREOF THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2016-12-08 WO claimed
US-5663030-A A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT XEROX CORPORATION (US) 1997-09-02 US claimed
CN-113730384-B Application of 4-methoxy phenanthrene-2, 5-diol in preparation of candida albicans resistant medicines or candida albicans resistant daily necessities 中山大学 2023-12-12 CN disclosed
US-20220145161-A1 GREEN COMPOSITIONS FOR USE IN DOWNHOLE AND INDUSTRIAL APPLICATIONS DELTA-ENERGY GROUP, LLC (US) 2022-05-12 US disclosed
CN-113730384-A Application of 4-methoxy phenanthrene-2, 5-diol in preparation of anti-candida albicans medicine or anti-candida albicans daily product 中山大学 2021-12-03 CN disclosed
US-11029303-B2 PAH antibodies and uses thereof THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2021-06-08 US disclosed
US-10961230-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2021-03-30 US disclosed
CN-112485343-A Underground water hydrocarbon pollutant source tracing method and system 长江大学 2021-03-12 CN disclosed
US-20190119260-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2019-04-25 US disclosed
EP-3080229-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-01-17 EP disclosed
WO-2003063771-A2 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS PHARMASSET LTD. (BB) 2003-08-07 WO disclosed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO disclosed
US-20030092878-A1 Composite type conductive polymer and process of producing aromatic compound TOYODA GOSEI CO., LTD. (JP) 2003-05-15 US disclosed
EP-1267359-A2 Composite type electroconductive polymer and process of producing an aromatic compound Toyoda Gosei Co., Ltd. (JP) 2002-12-18 EP disclosed
US-4741981-A Photosensitive material for electrophotography contains organic phosphite compounds RICOH CO., LTD. (JP) 1988-05-03 US disclosed
US-4661428-A HIGH ENERGY DENSITY; LIGHTWEIGHT SUBSTRATES RICOH CO., LTD. (JP) 1987-04-28 US disclosed
US-4521504-A DICHROMATIC IMAGES-CONDUCTIVE SUBSTRATE LAMINATED WITH PHOTOCONDUCTIVE RICOH COMPANY, LTD. (JP) 1985-06-04 US disclosed
US-4370398-A Electrostatic copying process RICOH COMPANY, LTD. (JP) 1983-01-25 US disclosed
US-4361638-A AMORPHOUS SILICON AND CARBON BASE MATERIAL DOPED WITH HYDROGEN AND FLUORINE FUJI PHOTO FILM CO., LTD. (JP) 1982-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092878-A1 Composite type conductive polymer and process of producing aromatic compound KCNH1, PIEZO1, KCNH3 CYP1A2 633/4885CYP2A6 2875/4885TDP1 2231/4885
US-10961230-B2 Materials for organic electroluminescent devices DDT, PNMT, INMT CYP1A2 1398/4885CYP2A6 4117/4885TDP1 1944/4885
US-11029303-B2 PAH antibodies and uses thereof PAH, AHR, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 CYP1A2 567/4885CYP2A6 1092/4885TDP1 1736/4885
US-20190119260-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, PNMT, INMT CYP1A2 1398/4885CYP2A6 4117/4885TDP1 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.